Earnings Labs
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA)

NASDAQ·Healthcare·Biotechnology

$12.58

-2.48%

Mkt Cap $200.14M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 2, 2026

$2.12M$859.00K-59.41%-$1.24-$1.70-37.10%——
Q1 2026

Feb 23, 2026

$1.98M$860.00K-56.60%-$1.24-$1.59-28.23%——
Q4 2025

Nov 10, 2025

$1.94M$12.47M+544.03%-$1.09-$1.27-16.51%——